Clinical trial Recruiting at 1 site Interventional Ages 1 Year and up

Comparing thick and mildly thick blenderized tube feeds for children

Official title: A Novel N-of-1 Randomized, Controlled, Clinical Trial to Assess the Effect of Blenderized Tube Feeds on Esophagogastric Physiology

Run by Boston Children's Hospital · NCT05417958 · Data updated 2026-11-12

This study is testing whether thicker or mildly thick blenderized tube feeds work better for kids with G-tubes who have stomach issues.

Quick facts

Study typeInterventional
Ages1 Year and up
SexAll
Enrollment40 (estimated)
SponsorBoston Children's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 12, 2023
Main results expectedOctober 1, 2027
Study endsApril 1, 2028
Registry record updatedApril 17, 2026
Trial IDNCT05417958 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children over one year old who have been dependent on G-tube feeding for more than six months and experience moderate gastrointestinal symptoms.

Probably not a fit

Patients with specific gastrointestinal diseases or conditions, such as cystic fibrosis or untreated malabsorptive intestinal diseases, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial is a 16-week multiple cross-over study designed to compare the effects of two types of blenderized tube feeds with varying viscosities in children who rely on G-tube feeding. The study will involve 40 participants who have been using G-tube feeding for over six months and experience moderate upper gastrointestinal symptoms. Each child will receive both types of feeds in a randomized order to assess their tolerance and symptom relief. The primary goal is to determine which viscosity of tube feed is better tolerated and more effective in alleviating feeding-related symptoms.

Why it matters

Potential benefit: If successful, this study could lead to improved feeding strategies for children with feeding disorders, enhancing their nutritional intake and quality of life.

How similar studies have gone: While there may be limited studies specifically comparing viscosities of blenderized tube feeds, the approach of using N-of-1 trials has shown promise in personalized medicine, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age \> 1 year
* \>90% of total calories via G-tube for \> 6 months
* G-tube diameter ≥ 14 French
* moderate severity of upper GI symptoms of nausea, bloating, postprandial fullness and early satiety defined as Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD) composite score \> 2
* anticipated stable GI-related medications for the duration of the study.

Exclusion Criteria:

* cystic fibrosis, primary ciliary dyskinesia, interstitial lung disease, bronchiolitis obliterans, or lung transplant
* untreated malabsorptive intestinal disease (e.g. Crohn's disease, celiac disease)
* Nissen fundoplication
* use of non-standard enteral formulas (e.g. ketogenic formulas) for the management of metabolic, endocrine or neurologic rare diseases
* allergy or intolerance to any component of the study diet
* inability to tolerate bolus gastric feeds.

Where it's running

  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.